Droplet Biosciences Cuts Cancer Genomic Analysis Time with NVIDIA GPUs

Mar 5, 2026
Droplet Biosciences is using NVIDIA's GPU-accelerated Parabricks software to reduce cancer genomic analysis times from days to hours, enabling faster post-surgery diagnostics.

Droplet Biosciences has reduced its genomic analysis time for residual cancer detection by adopting NVIDIA's AI infrastructure, announced in a press release. The company's LymphDetect test, which identifies residual cancer in lymphatic fluid after tumor removal, now processes data significantly faster using NVIDIA Parabricks software.

By moving from CPU-based systems to GPU-accelerated workflows, Droplet shortened key bioinformatics steps substantially. Variant calling times dropped from up to 36 hours to under three hours, sequence alignment from around ten hours to under one, and overall analysis timelines from ten days to two days. These improvements are powered by NVIDIA's L4 Tensor Core and L40S GPUs.

Droplet noted that despite higher hourly GPU costs, the shorter runtime lowers the total cost per sample and supports scalability in clinical use. The company plans to further optimize its workflows with the goal of achieving one-day analysis for post-surgical cancer detection.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Guide
Specialist Ambient Medical Scribe Vendors

Specialist Ambient Medical Scribe Vendors

AI scribes that turn medical consultations into draft clinical notes

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.